Publications
& Policy

In this letter to the European Commission we highlight the private equity and venture capital industry's suggestions surrounding the upcoming Omnibus Sustainability Package including the CSRD, CSDDD, and the Taxonomy.

This response asks IOSCO to carefully draft its Recommendations to acknowledge very specific types of open-ended structures, known as “semi-liquid” funds.

Started in 2021 as an extensive analysis of the venture deals involving Romanian startups, the report expanded to showcase the region’s dynamic of the venture deals raised yearly by tech startups, from early-stage pre-seed and seed rounds to late-stage series rounds. This is the 5th edition of the report and the 2nd edition when the dataset has been expanded to the whole Eastern European region, striving to surface the deals behind the entire region and draw insights on how the industry in this part of Europe is shaped and is finding its edge, making it one of the world’s startup powerhouses.

In 2024, despite global economic challenges, investment in healthcare startups and scaleups reached a record-breaking €350 million, marking a 55% increase from the previous year. The report, compiled by Biocat, presents key data on healthcare innovation indicators since 2009. Catalonia’s healthcare ecosystem ranks third in the region in terms of value-added and employment, demonstrating its strategic significance.

The Venture Capital Monitor (VeM) reports on operations in Italy in 2024. The study has been realized by the Observatory Venture Capital Monitor – VeM active at LIUC University and AIFI and realized thanks to the contribution of Intesa Sanpaolo Innovation Center and KPMG and the institutional support of CDP Venture Capital SGR and IBAN, with the objective of developing a permanent monitoring of early stage institutional activity.

With the 2025 data collection and reporting season in full swing, our expert speakers provided a comprehensive walkthrough of the structure and technical details of the 2024 Invest Europe ESG Reporting Template.

Representatives of the EU and UK-based financial services industries met on 11 February 2025 in Brussels to discuss their respective priorities and shared challenges on the eve of the latest EU-UK Financial Regulatory Forum meeting and agreed on the following statement.

Arthur D. Little: The potential of AI is vast, but its true impact often lies not in the technology itself, but in the people who wield it. Success requires balancing technical mastery with a broader ability to integrate knowledge and systems. It also calls for a cultural shift — one that fosters collaboration, trust, and a willingness to reimagine traditional approaches. The report is not intended to be just as an analysis, but also an invitation to take action.

As a founding member and long-standing supporter of the IPEV Valuation Guidelines, Invest Europe welcomes the opportunity to contribute to the 2025 review. After extensive consultation with our Professional Standards Committee and its members, we are pleased to provide our feedback.

During this webinar, we explored practical AI use cases with the help of our expert speakers.

In this letter to the European Commission, we outline our perspectives on the Platform on Sustainable Finance’s paper regarding product categorisation under SFDR (2.0).

Antler's fourth annual ESG and Impact Report examines how sustainability creates value in venture capital, with a focus on economic and business outcomes. Backed by data and case studies, this report highlights how integrating sustainability drives resilience, growth, and competitive advantage across both investment strategies and the portfolio companies.

EPO analysed 6,100 European and 8,000 U.S. investors to identify those prioritising patented technology when backing businesses. To achieve this, they introduced the Technology Investor Score (TIS) — a new metric measuring the proportion of companies in an investor’s portfolio that have filed patent applications. Leveraging this metric, the study creates a comprehensive mapping of specialised technology investors available to European startups and explores key areas of interest for European competitiveness.

Global deal activity surged in 2024, spurred by a large number of megadeals that resulted in the second-highest year on record in North America and a record-breaking year in Europe. Biopharma buyouts are seeing significant movement across the world, including a number of sizable deals. Healthcare IT continues to benefit from providers’ reliance on technology to boost operating efficiencies, investments in clinical trial IT infrastructure, and payer focus on advanced analytics. Key trends include innovation at mid-market funds, more carve-outs, a sharper focus on exit value maximization, and evolution of the investment landscape in Asia-Pacific.

Foreign capital plays a vital role in financing EU companies. Today, more foreign capital flows to EU venture funds than EU capital flows to non-EU funds. This demonstrates both the value of European businesses and a gap in domestic capital. Around 40% of capital in private markets originates outside the EU.

Foreign investors should not be discouraged from committing capital to European businesses through PE/VC funds. Current FDI regimes, designed to prevent foreign control of strategic assets, are less applicable to PE/VC structures. Investors in such funds do not exercise control over target companies; instead, they invest in the fund manager’s capacity to identify and support businesses.